查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
羊膜产品市场 - 全球规模、份额、趋势分析、机会、预测报告，2019-2030
市场调查报告书
商品编码
1410992

羊膜产品市场 - 全球规模、份额、趋势分析、机会、预测报告，2019-2030

Amniotic Products Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type ; By End User ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

至2030年，全球羊膜产品市场规模将超过13亿美元，2024年至2030年复合年增长率为8.56%

由于人们对羊膜产品的好处的认识不断提高以及对羊膜产品研发的投资不断增加，全球羊膜产品市场正在受到越来越多的关注。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计，2023 年全球羊膜产品市场规模将达到 8.104 亿美元。 BlueWeave预测，在2024年至2030年的预测期内，全球羊膜产品市场规模将以8.56%的复合年增长率成长，到2030年将达到13.262亿美元。羊膜产品在皮肤和眼部疾病治疗中的使用增加以及溃疡等慢性伤口发病率的增加是全球羊膜产品市场的关键驱动因素。此外，增加有关羊膜产品的研发计划预计将在分析期间推动市场成长。

该报告的详细分析提供了有关成长潜力、未来趋势和全球羊膜产品市场的资讯。它还揭示了推动市场总规模预测的因素。该报告提供了全球羊膜产品市场的最新技术趋势和业界考察，并承诺帮助决策者做出明智的策略决策。它还分析了市场成长驱动因素、挑战和竞争动态。

目录

第一章 研究框架

第 2 章执行摘要

第三章 全球羊膜产品市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 慢性伤口盛行率增加
      • 提高人们对羊膜产品益处的认识
      • 加大羊膜产品研发投入
    • 抑制因素
      • 羊膜的可得性有限
      • 来自替代伤口护理产品的竞争
    • 机会
      • 扩大再生医学的应用
      • 新兴市场需求不断成长
    • 任务
      • 保持羊膜产品的品质和一致性
      • 对医疗保健专业人员进行羊膜产品的教育
  • 科技进步/最新发展
  • 消费者行为与洞察
  • 法律规范
  • 波特五力分析

第四章 全球羊膜产品市场概况

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按类型
      • 冷冻保存羊膜
      • 脱水羊膜
    • 按最终用户
      • 医院及门诊手术中心
      • 其他的
    • 按用途
      • 创伤护理
      • 整形外科
      • 眼科
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第五章 北美羊膜产品市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按类型
    • 按最终用户
    • 按用途
    • 按国家/地区
      • 美国
      • 加拿大

第六章 欧洲羊膜产品市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按类型
    • 按最终用户
    • 按用途
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他的

第七章亚太羊膜产品市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按类型
    • 按最终用户
    • 按用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 其他的

第八章拉丁美洲羊膜产品市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按类型
    • 按最终用户
    • 按用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他的

第九章中东及非洲羊膜产品市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 按类型
    • 按最终用户
    • 按用途
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他的

第10章竞争形势

  • 主要企业及其产品列表
  • 2023年全球羊膜产品市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 主要策略发展（合併、收购、合作伙伴关係等）

第十一章地缘政治紧张局势对全球羊膜产品市场的影响

第十二章 公司简介（公司简介、财务矩阵、竞争形势、关键人力资源、主要竞争对手、联络地址、策略展望、SWOT分析）

  • MiMedx Group
  • Organogenesis
  • Smith &Nephew
  • Integra LifeSciences
  • Amniox Medical
  • AmnioTech
  • Skye Biologics
  • Applied Biologics
  • TissueTech
  • Katena Products
  • 其他主要企业

第十三章 关键策略建议

第14章调查方法

简介目录
Product Code: BWC24030

Global Amniotic Products Market Size Set to Surpass USD 1.3 Billion by 2030, Expanding at CAGR of 8.56% During 2024-2030.

Global Amniotic Products Market is gaining traction because of the growing awareness about the benefits of amniotic products and increasing investments in amniotic product research and development.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Amniotic Products Market size at USD 810.4 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Amniotic Products Market size to grow at a CAGR of 8.56% reaching a value of USD 1,326.2 million by 2030. The increasing use of amniotic products in the treatment of skin and eye conditions, as well as the growing incidence of chronic wounds, such as ulcers, are significant driving factors for the Global Amniotic Products Market. Moreover, over the period in analysis, it is expected that growing number of research and development programs on amniotic products will propel market growth.

Opportunity: Increasing number of amniotic product launches

The rising adoption of amniotic products in the healthcare sector owing to their therapeutic properties is also influencing product launches and research and development programs in the field. For instance, Amnio Technology, a United States-based developer and manufacturer of amnion-derived technologies, announced the launch of two new PalinGen membrane products, PalinGen Dual-Layer Membrane, and Dual Layer PalinGen X-Membrane. Versea Health, Inc., another US-based pharmaceutical products company, is launching Biovance 3L ocular tri-layer human amniotic membrane.

Global Amniotic Products Market - By End User

Based on end user, the Global Amniotic Products Market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment holds the largest share of the Global Amniotic Products Market by end user. The growth of the segment is mainly attributed to the high number of outpatient visits for wound treatment and surgical procedures. Amniotic membranes are mostly obtained at hospitals for use in tendon and ligament repair or for ophthalmic purposes. Hospital billing and reimbursement for these products are also easily obtained, which is a key factor contributing to the growth of the hospitals segment.

Impact of Escalating Geopolitical Tensions on Global Amniotic Products Market

The escalating geopolitical tensions are negatively impacting the growth of the Global Amniotic Products Market. Ukraine has a flourishing medical tourism sector. The country offers cost-effective quality healthcare. Ukraine's medical sector was increasingly becoming the hub for specialized treatments not readily available in other countries. However, with Russia's war on Ukraine, medical tourism dwindled, and the number of surgeries performed in the country declined at a staggering rate owing to the sensitive situation in the country and a lack of resources. It resulted in a significant decline in the demand for amniotic products for healthcare purposes as well as hindered research and development activities, limiting its market growth.

Global Amniotic Products Market - By Region

The in-depth research report on the Global Amniotic Products Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Amniotic Products Market. The rising healthcare expenditure, coupled with the increasing prevalence of chronic wounds and diabetes, as well as the high concentration of amniotic product manufacturers, are directly influencing market growth. However, the Asia Pacific region is projected to register a high growth rate during the forecast period owing to the growing geriatric population in East Asian countries, including Japan and South Korea.

Competitive Landscape

Major players operating in the Global Amniotic Products Market include: MiMedx Group, Organogenesis, Smith & Nephew, Integra LifeSciences, Amniox Medical, AmnioTech, Skye Biologics, Applied Biologics, TissueTech, and Katena Products. These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Amniotic Products Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Amniotic Products Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Amniotic Products Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Amniotic Products Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Chronic Wounds
      • 3.2.1.2. Growing Awareness of the Benefits of Amniotic Products
      • 3.2.1.3. Increasing Investments in Amniotic Product Research and Development
    • 3.2.2. Restraints
      • 3.2.2.1. Limited Availability of Amniotic Membranes
      • 3.2.2.2. Competition from Alternative Wound Care Products
    • 3.2.3. Opportunities
      • 3.2.3.1. Expanding Applications in Regenerative Medicine
      • 3.2.3.2. Growing Demand in Emerging Markets
    • 3.2.4. Challenges
      • 3.2.4.1. Maintaining the Quality and Consistency of Amniotic Products
      • 3.2.4.2. Educating Healthcare Professionals about Amniotic Products
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Consumer Behavior and Insights
  • 3.5. Regulatory Framework
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Intensity of Rivalry

4. Global Amniotic Products Market Overview

  • 4.1. Market Size & Forecast, 2019-2030
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Cryopreserved Amniotic Membrane
      • 4.2.1.2. Dehydrated Amniotic Membrane
    • 4.2.2. By End User
      • 4.2.2.1. Hospitals & Ambulatory Surgical Centers
      • 4.2.2.2. Others
    • 4.2.3. By Application
      • 4.2.3.1. Wound Care
      • 4.2.3.2. Orthopedics
      • 4.2.3.3. Ophthalmology
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Amniotic Products Market

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By End User
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Type
      • 5.2.4.1.2. By End User
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Type
      • 5.2.4.2.2. By End User
      • 5.2.4.2.3. By Application

6. Europe Amniotic Products Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By End User
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By End User
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Type
      • 6.2.4.3.2. By End User
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Type
      • 6.2.4.4.2. By End User
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Type
      • 6.2.4.5.2. By End User
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Type
      • 6.2.4.6.2. By End User
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Type
      • 6.2.4.7.2. By End User
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Type
      • 6.2.4.8.2. By End User
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Type
      • 6.2.4.9.2. By End User
      • 6.2.4.9.3. By Application

7. Asia Pacific Amniotic Products Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By End User
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By End User
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By End User
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By End User
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By End User
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By End User
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By End User
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By End User
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By End User
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Type
      • 7.2.4.10.2. By End User
      • 7.2.4.10.3. By Application

8. Latin America Amniotic Products Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By End User
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By End User
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By End User
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By End User
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By End User
      • 8.2.4.5.3. By Application

9. Middle East & Africa Amniotic Products Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By End User
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By End User
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By End User
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By End User
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By End User
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Type
      • 9.2.4.6.2. By End User
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Type
      • 9.2.4.7.2. By End User
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Type
      • 9.2.4.8.2. By End User
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Amniotic Products Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Geopolitical Tension on Global Amniotic Products Market

12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. MiMedx Group
  • 12.2. Organogenesis
  • 12.3. Smith & Nephew
  • 12.4. Integra LifeSciences
  • 12.5. Amniox Medical
  • 12.6. AmnioTech
  • 12.7. Skye Biologics
  • 12.8. Applied Biologics
  • 12.9. TissueTech
  • 12.10. Katena Products
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations